Diferencia entre revisiones de «Bumetanide»
Sin resumen de edición |
(Switch SMW query from broadtable to table format for better layout with TOC) |
||
| (No se muestran 6 ediciones intermedias de 4 usuarios) | |||
| Línea 4: | Línea 4: | ||
==Administration== | ==Administration== | ||
*Type: Loop [[diuretic]] | *Type: Loop [[diuretic]] | ||
*Dosage Forms: | *Dosage Forms: injectable solution, tablet | ||
*Dosage Strengths: injectable solution: 0.25mg/mL; tablet: 0.5, 1, 2mg | |||
*Routes of Administration: IV, PO | *Routes of Administration: IV, PO | ||
*Common Trade Names: Bumex | *Common Trade Names: Bumex, Burinex | ||
==Adult Dosing== | ==Adult Dosing== | ||
''40mg [[furosemide]] = 20mg [[torsemide]] = 1mg bumetanide'' | ''40mg [[furosemide]] = 20mg [[torsemide]] = 1mg bumetanide = 50 mg [[ethacrynic acid]]'' | ||
*0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day | *0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
| Línea 42: | Línea 43: | ||
*Rapid onset | *Rapid onset | ||
*Half-life: 1-6 hours | *Half-life: 1-6 hours | ||
*Metabolism: | *Metabolism: Partially metabolized in liver | ||
*Excretion: Mostly renal | *Excretion: Mostly renal | ||
| Línea 49: | Línea 50: | ||
==Comments== | ==Comments== | ||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Bumetanide]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
*[[Antihypertensives]] | |||
*[[Diuretics]] | *[[Diuretics]] | ||
Revisión actual - 21:58 20 mar 2026
General
- 80-100% oral bioavailability as opposed to furosemide[1]
Administration
- Type: Loop diuretic
- Dosage Forms: injectable solution, tablet
- Dosage Strengths: injectable solution: 0.25mg/mL; tablet: 0.5, 1, 2mg
- Routes of Administration: IV, PO
- Common Trade Names: Bumex, Burinex
Adult Dosing
40mg furosemide = 20mg torsemide = 1mg bumetanide = 50 mg ethacrynic acid
- 0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: no adjustment
- Hepatic dosing: use lowest dose necessary, titrate slowly
Contraindications
- Allergy to class/drug
- Anuria
- Hepatic coma
- Severe electrolyte depletion
Adverse Reactions
Serious
- SJS
- Encephalopathy
- Thrombocytopenia
Common
- Hypotenchion
- Hypouricemia, hypokalemia, hypochloremia
- Cramps
- Dizziness, headache
- Nausea
Pharmacology
- Rapid onset
- Half-life: 1-6 hours
- Metabolism: Partially metabolized in liver
- Excretion: Mostly renal
Mechanism of Action
- Inhibits the reabsorption of sodium and chloride in the ascending limb of the loop of Henle
Comments
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Volume overload | 1-2mg IV (equivalent to furosemide 40-80mg) | Loop diuretic alternative | IV | Adult |
See Also
References
- ↑ Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.